Clinical Trial Update: Fulvestrant in Treating Patients With Recurrent Ovarian Epithelial Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating fulvestrant for recurrent ovarian epithelial cancer has completed with results posted in 2010.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer
• Ovarian Epithelial Cancer

Drugs mentioned

• Fulvestrant (fulvestrant)

Snippet

Sponsor: Masonic Cancer Center, University of Minnesota | Conditions: Ovarian Cancer | Phase 2 | Status: COMPLETED | Results posted: 2010-03-17